Fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection of circulating ESR1 mutation in HR+HER2-metastatic breast cancer patients: Results of PADA-1, a UCBG-GINECO randomized phase 3 trialFrancois-Clement Bidard,Anne-Claire Hardy-Bessard,Thomas Bachelot,Jean-Yves Pierga,Jean-Luc Canon,Florian Clatot,Fabrice Andre,Thibault De La Motte Rouge,Barbara Pistilli,Florence Dalenc,Nadine Dohollou, Olivier Arsene,Thierry Petit,Cecilia Riedl,Francois Morvan, Adina Marti,Emma Lachaier, Mihaela Achille,Michel Gozy, Anne Escande,Dominique Mille,Fanny Trouboul,Laurent Arnould, Ivan Bieche,Anne Pradines,Jerome Lemonnier,Frederique Berger,Suzette DelalogeCANCER RESEARCH（2022）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
